mRNA Vaccines for the Win; But mRNA Therapies…?
Elie Dolgin • November 24, 2021
Unclear road ahead for biotech behind COVID-19 immunization successes
Continue reading at IEEE Spectrum.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.